Analystreport

Osmotica Pharmaceuticals PLC (NASDAQ: OSMT) had its "buy" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.

Osmotica Pharmaceuticals plc - Ordinary Shares  (OSMT) 
Last osmotica pharmaceuticals plc - ordinary shares earnings: 3/18 04:05 pm Check Earnings Report